Antimicrobials News

At the end of this month, Anthony S. Fauci, MD, will officially step down as director of the National Institute of Allergy and Infectious Diseases, which he has led for nearly 4 decades.

New antimicrobial dispensing within 28 days of initial treatment was associated with uncomplicated UTIs where the uropathogen was not susceptible to initial treatment, according to a recent study.

Nearly half of all Streptococcus pneumoniae isolates collected from U.S. adults as part of a large study were resistant to at least one drug, researchers found.

The FDA approved ibrexafungerp, an oral, non-azole antifungal drug, for reducing the number of recurrent vulvovaginal candidiasis incidences, according to a press release.

Wanted: a prominent scientist to lead a $6.3 billion research organization.

When I was in high school, I had an opportunity to shadow the medical field through the Girl Scouts. This led to me volunteering at a hospital during undergrad.

Herpes simplex encephalitis (HSE) is likely the most serious herpes infection patients can face. Treatment options for HSE are very limited, with IV acyclovir the only approved antiviral for this devastating infection.

Letermovir effectively prevented cytomegalovirus disease among kidney transplant patients with fewer side effects than valganciclovir, according to a study presented at IDWeek.

WASHINGTON — Decreases in urine cultures for asymptomatic bacteriuria reduced unnecessary antibiotic prescribing for UTIs, according to a study presented at IDWeek.

WASHINGTON — Cefepime-taniborbactam was statistically superior to meropenem for the treatment of complicated UTIs, including acute pyelonephritis, according to data presented at IDWeek.